Clinical efficacy of Fuzheng Jiedu Xiaoyong granules in advanced colorectal cancer (spleen deficiency and stasis toxin syndrome)

Table 1 Comparisons of baseline data between the two groups (n = 39 in each group)

Item		Treatment group	Control group	χ2/t	P value
Sex	Male	27	25
	Female	12	14	0.058	0.81
Age (years)		60.53 ± 7.88	61.20 ± 10.00	-0.3271	0.745
Tumor location	Colon	23	22
	Rectum	16	17	0.053	0.81
Metastatic site	Liver	26	24
	Lungs	16	14	0.013	0.908
Time since initial diagnosis (month)	> 6	11	15
	< 6	28	24	0.923	0.337
Prior treatment modalities	Surgery	16	16
	Chemotherapy	12	16	0.086	0.769

¹t value.